54.23
-0.66
(-1.20%)
At close: January 10 at 4:16:03 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
15,003,000.00
13,860,000.00
13,066,000.00
16,207,000.00
14,052,000.00
Investing Cash Flow
-22,502,000.00
-2,295,000.00
-1,062,000.00
-538,000.00
-10,859,000.00
Financing Cash Flow
7,736,000.00
-9,416,000.00
-16,962,000.00
-16,224,000.00
-1,151,000.00
End Cash Position
7,805,000.00
11,519,000.00
9,325,000.00
14,316,000.00
14,973,000.00
Capital Expenditure
-1,200,000.00
-1,209,000.00
-1,118,000.00
-973,000.00
-753,000.00
Issuance of Debt
20,596,000.00
4,455,000.00
5,926,000.00
--
6,945,000.00
Repayment of Debt
-7,873,000.00
-3,879,000.00
-11,431,000.00
-6,022,000.00
-2,750,000.00
Repurchase of Capital Stock
--
-5,155,000.00
-8,001,000.00
-6,287,000.00
-1,546,000.00
Free Cash Flow
13,803,000.00
12,651,000.00
11,948,000.00
15,234,000.00
13,299,000.00
12/31/2020 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
JNJ.CL Johnson & Johnson
619,740.00
+1.21%
0R34.IL Johnson & Johnson
143.00
+0.49%
LILY34.SA Eli Lilly and Company
162.20
+1.99%
GRF.MC Grifols, S.A.
9.06
-0.57%
NOV.DE Novo Nordisk A/S
84.60
-0.31%
NONOF Novo Nordisk A/S
85.80
0.00%
SNY Sanofi
48.73
-1.02%
MRK Merck & Co., Inc.
99.25
-0.60%
AZN AstraZeneca PLC
67.01
+0.65%
PFE Pfizer Inc.
26.72
-0.52%